We select products from a broad European network of manufacturers and wholesalers. Competitive purchasing based on quality, availability and commercial opportunity, including EU parallel products with a purchasing advantage.
We select products from a broad European network of manufacturers and wholesalers. Competitive purchasing based on quality, availability, and commercial opportunities, including EU parallel imported products with purchasing advantages.
Our Quality and Regulatory Affairs team manages all required licences and national approvals. A product is only released to the market once it’s fully compliant.
In our own production facility, we ensure EU packaging complies with national regulations: adding translated package leaflets and mandatory labelling, and adapting packaging for the target market.In our own production facilities, we ensure that EU packaging complies with national regulations by adding translated package leaflets and mandatory labelling, and adapting packaging for the target market.
From our climate-controlled warehouse, we manage distribution to wholesalers, pharmacies, drugstores and webshops in the Netherlands and Belgium, in line with GDP guidelines.
Our team of account managers supports retailers with personal advice, promotions and temporary offers, for both physical stores and online channels.
Based on consumer behaviour and current market data, we advise retailers on an optimal product mix, for better shelf presentation and higher category revenue.
The prices and availability of medicines and healthcare products can vary significantly between national markets, even within a highly integrated region such as the European Union. These differences create a commercial opportunity to source registered EU medicines and approved EU healthcare products from lower-priced markets and supply them to markets where prices are higher. This process is known as parallel import.
A key characteristic of parallel import is that the medicines and healthcare products are manufactured by the original manufacturer but distributed through an independent distribution channel (a wholesaler), rather than through the manufacturer’s official distribution network.
Although the imported EU product is the same medicine or healthcare product, the distribution route differs. Parallel import is legally permitted within the European Union, based on the principle of exhaustion of intellectual property rights and the free movement of goods.
From manufacturer to consumer, every parallel-imported product goes through several stages:
Produces the original EU product
Purchasing and storage from the market
Sourcing, registration & national distribution
Adaptation to national regulations
Delivery to licensed outlets
Safe, affordable and fully approved product
Parallel-imported EU medicines must obtain a national licence and regulatory approval before they can be placed on the relevant national market, making them completely safe.
In addition, parallel-imported EU medicines and healthcare products generally require packaging adjustments to comply with national regulations.
These adjustments include the following:
Our own registration team manages the entire process, from application and repackaging through to national distribution.
In our own GMP-certified production facility, we independently carry out repackaging and relabelling work for OTC products.
